Pasetto A, Lu YC(2023) Editorial: Personalized immunotherapy for cancer Front Oncol, 13, 1171907 DOI 10.3389/fonc.2023.1171907, PubMed 36959783
Thomsen LCV, Honoré A, Reisæter LAR, Almås B, Børretzen A, Helle SI, Førde K, Kristoffersen EK, Kaada SH, Melve GK, Haslerud TM, Biermann M, Bigalke I, Kvalheim G, Azeem W, Olsen JR, Gabriel B, Knappskog S, Halvorsen OJ, Akslen LA, Bahn D, Pantel K, Riethdorf S, Ragde H, Gjertsen BTet al.(2023) A phase I prospective, non-randomized trial of autologous dendritic cell-based cryoimmunotherapy in patients with metastatic castration-resistant prostate cancer Cancer Immunol Immunother(in press) DOI 10.1007/s00262-023-03421-7, PubMed 36939854
Lilleby W, Seierstad T, Inderberg EM, Hole KH(2023) Impact of human telomerase reverse transcriptase peptide vaccine combined with androgen deprivation therapy and radiotherapy in de novo metastatic prostate cancer: Long-term clinical monitoring Int J Cancer, 152(10), 2166-2173 DOI 10.1002/ijc.34448, PubMed 36715014